Advanced

Recommendations for follow-up of muscle-invasive bladder cancer patients : A consensus by the international bladder cancer network

Zuiverloon, Tahlita C.M.; van Kessel, Kim E.M.; Bivalacqua, Trinity J.; Boormans, Joost L.; Ecke, Thorsten H.; Grivas, Petros D.; Kiltie, Anne E.; Liedberg, Fredrik LU ; Necchi, Andrea and van Rhijn, Bas W., et al. (2018) In Urologic Oncology: Seminars and Original Investigations 36(9). p.423-431
Abstract

Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to infer on what the preferred follow-up schema would be for an individual patient. Herein, we aim to synthesize recommendations for follow-up of patients with MIBC for easy reference. Methods: A multidisciplinary MIBC expert panel from the International Bladder Cancer Network was assembled to critically assess currently available major guidelines on surveillance of MIBC patients. Recommendations for follow-up were extracted and critically evaluated. Important considerations for guideline... (More)

Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to infer on what the preferred follow-up schema would be for an individual patient. Herein, we aim to synthesize recommendations for follow-up of patients with MIBC for easy reference. Methods: A multidisciplinary MIBC expert panel from the International Bladder Cancer Network was assembled to critically assess currently available major guidelines on surveillance of MIBC patients. Recommendations for follow-up were extracted and critically evaluated. Important considerations for guideline assessment included both aspects of oncological and functional follow-up-frequency of visits, the use of different imaging modalities, the role of cytology and molecular markers, and the duration of follow-up. Outcome: An International Bladder Cancer Network expert consensus recommendation was constructed for the follow-up of patients with MIBC based on the currently available evidence-based data.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Bladder cancer, Disease management, Follow-up, Guidelines, Muscle invasive
in
Urologic Oncology: Seminars and Original Investigations
volume
36
issue
9
pages
423 - 431
publisher
Elsevier
external identifiers
  • scopus:85042474131
ISSN
1078-1439
DOI
10.1016/j.urolonc.2018.01.014
language
English
LU publication?
yes
id
a0013273-ff4e-4437-b2a3-b0f6349fa663
date added to LUP
2018-03-09 09:59:49
date last changed
2019-04-23 04:28:50
@article{a0013273-ff4e-4437-b2a3-b0f6349fa663,
  abstract     = {<p>Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to infer on what the preferred follow-up schema would be for an individual patient. Herein, we aim to synthesize recommendations for follow-up of patients with MIBC for easy reference. Methods: A multidisciplinary MIBC expert panel from the International Bladder Cancer Network was assembled to critically assess currently available major guidelines on surveillance of MIBC patients. Recommendations for follow-up were extracted and critically evaluated. Important considerations for guideline assessment included both aspects of oncological and functional follow-up-frequency of visits, the use of different imaging modalities, the role of cytology and molecular markers, and the duration of follow-up. Outcome: An International Bladder Cancer Network expert consensus recommendation was constructed for the follow-up of patients with MIBC based on the currently available evidence-based data.</p>},
  author       = {Zuiverloon, Tahlita C.M. and van Kessel, Kim E.M. and Bivalacqua, Trinity J. and Boormans, Joost L. and Ecke, Thorsten H. and Grivas, Petros D. and Kiltie, Anne E. and Liedberg, Fredrik and Necchi, Andrea and van Rhijn, Bas W. and Roghmann, Florian and Sanchez-Carbayo, Marta and Schmitz-Dräger, Bernd J. and Wezel, Felix and Kamat, Ashish M.},
  issn         = {1078-1439},
  keyword      = {Bladder cancer,Disease management,Follow-up,Guidelines,Muscle invasive},
  language     = {eng},
  number       = {9},
  pages        = {423--431},
  publisher    = {Elsevier},
  series       = {Urologic Oncology: Seminars and Original Investigations},
  title        = {Recommendations for follow-up of muscle-invasive bladder cancer patients : A consensus by the international bladder cancer network},
  url          = {http://dx.doi.org/10.1016/j.urolonc.2018.01.014},
  volume       = {36},
  year         = {2018},
}